chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever or Chills  Cough  Shortness of Breath  Fatigue  Muscle or body aches  Headache  Sore throat  Congestion or running nose  Video visit in this covid 19 pandemic     Patient ID: Patient is a 50 y.o. male who is here for chief complaint of:   Chief Complaint Patient presents with ? Covid-19 Screening     Pt c/o fever, chills, body ache since came back; pt is fully covid vaccinated  cough is dry, sore throat, since 1 day Fever up to 100, sweating Sinuses hurt Taking Advil Was in the water at times with the red tide warning Called off work today Not feeling SOB Non smoker, no h/o copd, asthma     HPI as above Has an older rx for albuterol from last year that seems to be helping States he usually gets a zpack and steroids for this sort of thing   Review of Systems  Constitutional: Positive for fatigue.  HENT: Positive for congestion and sore throat.   Eyes: Negative.   Respiratory: Positive for cough.   Cardiovascular: Negative.   Gastrointestinal: Negative.       family history includes Cancer in his father, father's brother, and father's sister; Diabetes in his father.
Hives on both legs and right arm 2 hours after administration of vaccines on 05/09/16, po Benadryl 4 ml given by parent and hives subsided within 1 hour. Recurred again at 4 a.m. 05/10/16 - Benadryl given and then recurred at 8 a.m.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated with, .5 ml VARIVAX injection by subcutaneously on 03-SEP-2012 (lot: 0966Z, pending lot validation, expired date: 21-JUL-2012). On 03-SEP-2012, the patient received VARIVAX that was expired. The patient was not experiencing any known symptoms. The outcome for the event was unknown. Additional information has been requested.
Mitral valve repair with placement of 5 CV GORE-TEX NeoChord loops to the prolapsing segments; recovery hospital stay. Hospital admission within 6 weeks of receiving the COVID vaccine.
This spontaneous report has been received from a pharmacist referring to a 62 year old male patient; with no known drug reactions/allergies and with no relevant medical history or concomitant therapies. On 13-OCT-2014, the patient was vaccinated with a dose of ZOSTAVAX (route of administration, frequency, lot# and expiration date were not provided) for prophylaxis. Then on 24-DEC-2016, the patient was vaccinated with another dose of ZOSTAVAX (route of administration, frequency, lot# and expiration date were not provided) for prophylaxis; the same date the patient also was vaccinated with influenza virus vaccine (unspecified) and tetanus toxoid (unspecified) (route of administration, frequency, lot# and expiration date were not provided) for prophylaxis. On 25-DEC-2016, the patient experienced rash and a high fever; and from an unspecified date in December 2016, the patient has been sick in bed (malaise). It was reported that the patient sought medical attention, he contacted the pharmacist but no treatment was given nor lab diagnostic studies were performed. At the time of reporting the outcome of the events was reported as not recovered. The relatedness between the events and ZOSTAVAX, influenza virus vaccine (unspecified) and tetanus toxoid was not reported. Additional information has been requested.
This study case was received from the investigator in a trial on 20 February 2014. A male subject (date of birth not reported) had received the following vaccines on 07 February 2014: ACAM2000 (lot number, route and site of administration not reported) and Anthrax (manufacturer, lot number, route and site of administration not reported) and one day later, on 08 February 2014 experienced chest pain and shortness of breath which resolved without any treatment. ECG appeared normal and PPD was normal. The subject's outcome was recovered on 10 February 2014. According to the investigator, if eRT returns otherwise, a follow-up report will submit. No further information was available at the time of the report. According to the investigator, the event of chest pain and shortness of breath was considered mild, an "other important event" and possibly related to vaccination. Documents held by sender: none.
3 cm erythema area (L) upper arm 20-25 red spots over trunk with a few vesicular.
rash that appeared approximately 9-10 days after she had the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash that appeared approximately 9-10 days after she had the vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash that appeared approximately 9-10 days after she had the vaccination). At the time of the report, RASH (rash that appeared approximately 9-10 days after she had the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
injection site was reddish pink radiating in a circular fashion to the inside of her arm and was warm to the touch
Post menopausal vaginal bleeding; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: Lot Number: ER8737), via an unspecified route of administration, administered in the left arm on 06Apr2021 at 10:30 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 11Apr2021 at 08:00, the patient experienced post menopausal vaginal bleeding. The patient did not receive treatment for the event. The outcome of the event was not recovered.
I am having and have been having serious pain in my arm and hand and wrist since the night after I recieved the vaccine.
broke out with chicken pox; This case was reported by a consumer via  interactive digital media and described the occurrence of chickenpox in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than a week after receiving Shingles vaccine, the patient experienced chickenpox. On an unknown date, the outcome of the chickenpox was unknown.   It was unknown if the reporter considered the chickenpox to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingles vaccine he broke out with chicken pox. The follow-up would not possible as no contact details were available. For tolerance of 2nd dose of Shingles vaccine, refer link case US2021AMR178363.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR178363:Same reporter
After shots flu like symptoms, night sweats, and fever, swelling of legs and lower joints( foot, ankle,andknees) over 2 yrs have passed since shots and still having join pains and swelling.
I had chills, a headache, body aches, and a temperature of 102. The temperature lasted for about 8 hours, and the symptoms were mostly resolved the next day (24 - 36 hours).
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 26-JUL-2016, the patient was vaccinated with an improperly stored dose of M-M-R II (albumin status was not reported) lot # L041455, expiration date 22-OCT-2016 and an improperly stored dose of VARIVAX, lot #L048468, expiration date 02-12-2017 (dose and route of administration were not reported for both vaccines). There was no adverse effect reported. Administered doses of vaccine experienced the temperature excursion of 70 degrees Fahrenheit for 1 hour. There were no previous temperature excursions. Additional information has been requested.
Chronic Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an attorney and describes the occurrence of HEADACHE (Chronic Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Chronic Headache). At the time of the report, HEADACHE (Chronic Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided.  Treatment information not provided.  On 19/Apr/2021, a lawyer reported that 13 other people have had chronic headache since receiving the vaccine.   This case was linked to MOD21-078107, MOD21-033662, MOD21-078198, US-MODERNATX, INC.-MOD-2021-080204, MOD-2021-015967 (E2B Linked Report).; Sender's Comments:  MOD21-078107: MOD21-033662: MOD21-078198: US-MODERNATX, INC.-MOD-2021-080204:MOD21-078196 MOD-2021-015967:Initial report
Patient reports that he experienced prolonged weakness and pain in both arms. He states that the pain is persistent still today 7 months after received these vaccines. He says that his right arm is still more sore than the left arm and he cannot do much still with the right arm. He is not able to lift the arm and he states he couldn't drink his coffee initially or write checks or use his credit card. He required assistance with all of these tasks. He says lifting things and twisting make it worse. He says he still feels a knot in his right arm where the SHINGRIX vaccine was administered.
Within 5-7 minutes of receiving shot i fainted/passed out. Onsite paramedics stated blood sugar, blood pressure, and pulse were within normal range after sitting on stretcher for 15 minutes. I signed a release refusing transport to hospital as i was feeling better. Throughout the first day I started feeling tired and sore but that was to be expected. Following day 4/11, extremely nauseous, headache, body aches and typical flu like symptoms, low grade fever of 100-101. At roughly 9:45 am and again at 11:25 am started throwing up bile/stomach acid.  Flu like symptoms did not subside until morning of 4/13.
Sore throat, congested throat and nose, coughing, headache and ear ache
I knew that I would have some discomfort in my left arm after taking the flue shot but it didn't let up it started to hurt when I move like bending down and picking something up off the floor also when I was trying to go to sleep I had to turn all kind of ways and trying to use a pillow to prop my arm up my mobility was off I have sharp pain throughout the day depending on how i move my arm getting out the tub washing my hair numous in my left hand. My Doctor refferd me to therapy3/19 and 3/23 and 3/25 and 3/30 and 4/1 which I complete and some exercises were better than others I still felt not enough improvement for my left arm. I am scheduled to get a shot on May 25, 2021 to help me coop with the pain that I'm st
Patient's mom called in because he had a 2-3 inch "red patch" on the back of his right thigh. No fever, still able to walk, was not hot to the touch but did complain when it was touched. Was instructed to have him be seen - once brought in to clinic, the rash was measured and there was a right anterolateral (thigh) with approx 11 cm erythematous flat plaque with an approx 7 cm central area of pink/purple discoloration. No edema, tenderness or warmth appreciated at site. Local skin reaction w/no systemic symptoms. Parent reassured that the reaction would resolve in the next 4-7 days if not gone in a week, call us.
This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (After second shot, ill/ so sick/ In bed the whole day), FEELING ABNORMAL (it was awful), PARAESTHESIA (tingling in arms/tingling in hands/Breaking things because fingers tingly), HYPOAESTHESIA (numbness in hands and arms/has been going on for over a year) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose < 24 days after 1st dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 026A21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced ILLNESS (After second shot, ill/ so sick/ In bed the whole day), PARAESTHESIA (tingling in arms/tingling in hands/Breaking things because fingers tingly), HYPOAESTHESIA (numbness in hands and arms/has been going on for over a year) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose < 24 days after 1st dose). 09-Apr-2021, the patient experienced FEELING ABNORMAL (it was awful). At the time of the report, ILLNESS (After second shot, ill/ so sick/ In bed the whole day), FEELING ABNORMAL (it was awful), PARAESTHESIA (tingling in arms/tingling in hands/Breaking things because fingers tingly) and HYPOAESTHESIA (numbness in hands and arms/has been going on for over a year) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose < 24 days after 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: Neck X-ray, Result in the middle, little bit of closing, but nothing to be concerned about..         No concomitant medication was reported. Patient was very healthy. Patient did not have COVID test or diagnosis. Patient reported that the events has been going on for over a year. Patient had been visited to local orthopedic specialist group and to physical therapy and they thought It was because of the shot. Had to be something to do with the shot and thought it was carpel tunnel, but not carpel tunnel. Caller stated she wanted the MRI but had to get physical therapy first. Patient was referred to physical therapy and had dry needling on hand and that was not working. Patient reported that putting earrings on was difficult. Treatment information reported as, patient was referred to physical therapy and had dry needling on hand and that was not working   This case was linked to MOD-2022-609318 (Patient Link).
That evening fever, aches, overall miserable, sore arm 4 days later my arm is still swollen and red.
Information has been received from a certified medical assistant concerning a 19 year old female with no pertinent medical history and no known drug allergies or reactions who on 19-AUG-2008 was vaccinated with a first dose of GARDASIL (lot # 660553/0070X, expiry date 22-OCT-2010), 0.5mL, intramuscularly. On 10-OCT-2008 she received second dose of GARDASIL (lot # 660612/0229X, expiry date: 30-OCT-2010) 0.5mL, intramuscularly. There was no concomitant medication. In May 2009, the patient was diagnosed with papilloma viral infection after administration of two doses of GARDASIL. In the same date HPV test was positive. The patient sought unspecified medical attention. At the time on the report the patient had not recovered from papilloma viral infection. Follow up information has been received via telephone call from a certified medical assistant who reported that on 03-JAN-2008 visit, the patient was not tested for Papilloma viral infection. GARDASIL first and second doses were given on 19-AUG-2008 and 10-OCT-2008 respectively. In May 2009, the patient was tested and found to be positive for Papilloma viral infection, although the physician felt the HPV pre-existed the administration of the vaccines (thus the reason why their office later indicated there was no adverse event). On 13-MAY-2010 third dose of GARDASIL (lot # 662299/1099Y) was administered. Additional information is not expected.
soreness in the shoulder to the back of the neck; red circle around injection site; itchy circle around injection site; knot feeling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red circle around injection site), INJECTION SITE PRURITUS (itchy circle around injection site), INJECTION SITE MASS (knot feeling at injection site) and ARTHRALGIA (soreness in the shoulder to the back of the neck) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m2oa) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (red circle around injection site), INJECTION SITE PRURITUS (itchy circle around injection site) and INJECTION SITE MASS (knot feeling at injection site). On an unknown date, the patient experienced ARTHRALGIA (soreness in the shoulder to the back of the neck). At the time of the report, INJECTION SITE ERYTHEMA (red circle around injection site), INJECTION SITE PRURITUS (itchy circle around injection site), INJECTION SITE MASS (knot feeling at injection site) and ARTHRALGIA (soreness in the shoulder to the back of the neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  Treatment details included Cold compress and Tylenol(paracetamol).
The vaccine doesn't work is useless.; Caller is calling regarding Paxlovid. She would also like to know if she stops taking Paxlovid, would the Covid return and get worse; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 2 diabetic" (unspecified if ongoing), notes: She said she is a Type 2 diabetic. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "The vaccine doesn't work is useless."; COVID-19 (medically significant), outcome "unknown", described as "Caller is calling regarding Paxlovid. She would also like to know if she stops taking Paxlovid, would the Covid return and get worse". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: would the Covid return and get worse. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
hasn't been feeling well 3 weeks after the injection; rash over a large area over my arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (hasn't been feeling well 3 weeks after the injection) and RASH (rash over a large area over my arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (hasn't been feeling well 3 weeks after the injection) and RASH (rash over a large area over my arm). At the time of the report, MALAISE (hasn't been feeling well 3 weeks after the injection) and RASH (rash over a large area over my arm) outcome was unknown.            No concomitants or treatment medications were reported. Treatment information was not updated.   This case was linked to MOD21-036991 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Contact information was updated.
Immunized on 6/18/07 then 6/20/07 noticed arm redness and swelling. Then 6/20/07 mnoticed underarm swelling and mass. Left anterior axillary lymphnode 2 cm largest diameter
Complaining of pain at injection site that increased to pain in shoulder when she lays on it or tries to put bra on.
His left arm is numb waking up this morning. He is dizzy and having trouble comprehending things. He has never acted this way before. Its like he in slow motion.
heat coming out from her injection site; itchy; rash around her belly button area had striations going from the belly button; big rash around the site of injection; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE WARMTH (heat coming out from her injection site), PRURITUS (itchy), RASH (rash around her belly button area had striations going from the belly button) and VACCINATION SITE RASH (big rash around the site of injection) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE WARMTH (heat coming out from her injection site), PRURITUS (itchy), RASH (rash around her belly button area had striations going from the belly button) and VACCINATION SITE RASH (big rash around the site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (heat coming out from her injection site), PRURITUS (itchy), RASH (rash around her belly button area had striations going from the belly button) and VACCINATION SITE RASH (big rash around the site of injection) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information use was not reported.  Treatment information was not provided.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with the doses of improperly stored GARDASIL 9 (lot #, expiration date, dose, route and site of administration were not reported). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.